bioAffinity Technologies GAAP EPS of -$4.74, revenue of $1.45M
Source: SeekingAlpha
2025-11-14 08:23:28 ET
More on bioAffinity Technologies
- bioAffinity Technologies launches $1.8M direct financing
- bioAffinity Technologies prices $4.8 million public offering; shares down over 30%
- Seeking Alpha’s Quant Rating on bioAffinity Technologies
- Historical earnings data for bioAffinity Technologies
- Financial information for bioAffinity Technologies
Read the full article on Seeking Alpha
For further details see:
bioAffinity Technologies GAAP EPS of -$4.74, revenue of $1.45M
bioAffinity Technologies Inc.
NASDAQ: BIAF
BIAF Trading
19.42% G/L:
$1.23 Last:
19,167,828 Volume:
$1.14 Open:
BIAF Latest News
March 10, 2026 07:47:00 am
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic
March 03, 2026 08:30:00 am
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients
BIAF Stock Data
$4,543,696
4,349,802
N/A
3
N/A
Medical Diagnostics & Screening
Healthcare
US
San Antonio
